IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11407736 B1

PDFFull Text
Date of Patent:
Aug. 09, 2022

Filed:

Sep. 04, 2020

Rip1 inhibitory compounds and methods for making and using the same

Applicant:

Rigel Pharmaceuticals, Inc., South San Francisco, CA (US);

Inventors:

Yan Chen, Foster City, CA (US);

Jiaxin Yu, Foster City, CA (US);

Simon Shaw, Oakland, CA (US);

Ihab Darwish, South San Franciso, CA (US);

Vanessa Taylor, San Francisco, CA (US);

Somasekhar Bhamidipati, Foster City, CA (US);

Zhushou Luo, San Jose, CA (US);

Rao Kolluri, Foster City, CA (US);

Assignee:

Rigel Pharmaceuticals, Inc., South San Francisco, CA (US);

Attorney:

Gabriel Magallanes

Primary Examiner:

Bruck Kifle

Int. Cl.
CPC ...
C07D 471/04 (2006.01); C07D 491/048 (2006.01); C07D 495/04 (2006.01); C07D 513/04 (2006.01); A61K 31/55 (2006.01); A61K 31/5517 (2006.01); A61K 31/54 (2006.01); C07D 401/14 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 405/14 (2006.01); C07D 471/08 (2006.01); C07D 487/04 (2006.01); C07D 491/107 (2006.01); A61K 31/553 (2006.01); C07D 267/02 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 493/04 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); A61K 31/553 (2013.01); C07D 267/02 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 471/08 (2013.01); C07D 487/04 (2013.01); C07D 491/107 (2013.01); C07D 493/04 (2013.01);
Abstract

Disclosed herein are kinase inhibitory compounds, such as a receptor-interacting protein-1 (RIP1) kinase inhibitor compounds, as well as pharmaceutical compositions and combinations comprising such inhibitory compounds. The disclosed compounds, pharmaceutical compositions, and/or combinations may be used to treat or prevent a kinase-associated disease or condition, particularly a RIP1-associated disease or condition.

Find Patent Forward Citations

Loading…